5 Einträge gefunden

1. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
2. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

   1. Huebner, Hanna
   2. Kurbacher, Christian M
   3. Kuesters, Geoffrey
   4. Hartkopf, Andreas D
   5. Lux, Michael P
   6. Huober, Jens
   7. Volz, Bernhard

   2020 - Forschungsinformationssystem des UKE
3. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

   1. Hartkopf, Andreas D
   2. Huober, Jens
   3. Volz, Bernhard
   4. Nabieva, Naiba
   5. Taran, Florin-Andrei
   6. Schwitulla, Judith
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
4. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

   1. Müller, Volkmar
   2. Nabieva, Naiba
   3. Häberle, Lothar
   4. Taran, Florin-Andrei
   5. Hartkopf, Andreas D
   6. Volz, Bernhard
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE
5. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

   1. Lux, Michael P
   2. Nabieva, Naiba
   3. Hartkopf, Andreas D
   4. Huober, Jens
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2018 - Forschungsinformationssystem des UKE - frei zugänglich